Chengdu Olymvax Biopharmaceuticals Inc. (SHA:688319)

China · Delayed Price · Currency is CNY

21.56

+1.03 (5.02%)

Jul 31, 2026, 3:00 PM CST

SHA:688319 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	774.47	704.16	588.86	496.12	547.48	487.15
Revenue Growth	27.90%	19.58%	18.69%	-9.38%	12.38%	52.18%
Gross Profit	704.18	641	559.09	459.39	504.48	458.79
Operating Income	64.41	32.73	21.62	3.51	14.7	93.89
Net Income	56.52	22.26	20.76	17.56	26.58	107.96
Earnings Per Share	0.14	0.05	0.05	0.04	0.07	0.28
EPS Growth	42.63%	7.23%	18.25%	-33.99%	-76.61%	182.95%

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	194.9	249.21	241.66	362.07	359.23	454.37
Total Debt	434.93	433.03	361.79	237.61	134.03	38.25
Net Cash (Debt)	-240.04	-183.82	-120.13	124.47	225.2	416.11
Net Cash Growth	-	-	-	-44.73%	-45.88%	381.08%
Net Cash Per Share	-0.59	-0.45	-0.30	0.31	0.56	1.08

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	103.57	105.49	-9.73	44	-24.55	39.96
Capital Expenditures	-103.33	-98.81	-207.32	-169.88	-200.69	-69.71
Free Cash Flow	0.24	6.68	-217.05	-125.88	-225.24	-29.75
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	90.92%	91.03%	94.94%	92.60%	92.14%	94.18%
Operating Margin	8.32%	4.65%	3.67%	0.71%	2.69%	19.27%
Pretax Margin	9.21%	4.53%	3.79%	3.15%	7.97%	22.00%
Profit Margin	7.30%	3.16%	3.52%	3.54%	4.85%	22.16%
FCF Margin	0.03%	0.95%	-36.86%	-25.37%	-41.14%	-6.11%

Dividends

Fiscal Year	FY 2023
Period Ending	Dec '23 Dec 31, 2023
Dividend Per Share	0.038
Dividend Per Share Growth	-
Dividend Yield	0.24%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 2, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	154.53	462.46	207.29	365.54	211.50	134.42
Forward PE	-	187.85	98.61	60.77	38.44	59.68
P/FCF Ratio	36235.11	1540.54	-	-	-	-
PS Ratio	11.29	14.62	7.31	12.94	10.27	29.79